The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Anti–β2‐glycoprotein I antibodies in complex with β2‐glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib‐IX‐V
Abstract
Objective: Results of previous studies suggest that anti–β 2‐glycoprotein I (anti‐β 2 GPI) antibodies in complex with β 2 GPI activate platelets in a dysregulated manner, potentially contributing to the prothrombotic tendency associated with the antiphospholipid syndrome (APS). We undertook this study to investigate the possible contribution of the GPIb‐IX‐V receptor to platelet activation mediated by the anti‐β 2 GPI antibody–β 2 GPI complex. Methods: In vitro methods were used in the present study. The interaction between β 2 GPI and the GPIbα subunit of the GPIb‐IX‐V receptor was delineated using direct binding and competitive inhibition assays. The interaction between the anti‐β 2 GPI antibody–β 2 GPI complex and platelets was studied using a novel method in which the Fc portion of the antibody was immobilized using protein A coated onto a microtiter plate. Platelet activation was assessed by two methods; one involved measuring thromboxane B 2 production and the other involved assessment of the activation of the phosphatidylinositol 3‐kinase/Akt/glycogen synthase kinase 3β intracellular signaling pathway. The contribution of the GPIbα receptor to platelet activation induced by the anti‐β 2 GPI antibody–β 2 GPI complex was assessed by observing the influence of 2 anti‐GPIbα antibodies (AK2 and SZ2) directed against distinct epitopes. Results: This study showed that β 2 GPI could bind to the GPIbα receptor. The anti‐β 2 GPI antibody–β 2 GPI complex was able to activate platelets, and this effect was inhibited by anti‐GPIbα antibody directed against epitope Leu‐36–Gln‐59, but not by anti‐GPIbα antibody directed against residues Tyr‐276–Glu‐282. Conclusion: Our findings show that inappropriate platelet activation by the anti‐β 2 GPI antibody–β 2 GPI complex via the GPIbα receptor may contribute to the prothrombotic tendency associated with APS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Laat, B., Derksen, R. H. W. M., Urbanus, R. T., & de Groot, P. G. (2005) · Blood · doi:10.1182/blood-2004-09-3387 · Cited by 378
Cited by
The ITP syndrome: pathogenic and clinical diversity
Cines, D. B., Bussel, J. B., Liebman, H. A., & Luning Prak, E. T. (2009) · Blood · doi:10.1182/blood-2009-01-129155 · Cited by 804
The Pathogenesis of the Antiphospholipid Syndrome
Giannakopoulos, B., & Krilis, S. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1112830 · Cited by 688
Self-citationInhibition of the mTORC Pathway in the Antiphospholipid Syndrome
Canaud, G., Bienaimé, F., Tabarin, F., Bataillon, G., Seilhean, D., Noël, L.-H., Dragon-Durey, M.-A., Snanoudj, R., Friedlander, G., Halbwachs-Mecarelli, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312890 · Cited by 355
The Pathogenicity of Anti-β 2GP1-IgG Autoantibodies Depends on Fc Glycosylation
Fickentscher, C., Magorivska, I., Janko, C., Biermann, M., Bilyy, R., Nalli, C., Tincani, A., Medeghini, V., Meini, A., Nimmerjahn, F., et al. (2015) · Journal of Immunology Research · doi:10.1155/2015/638129 · Cited by 37
Du, V. X., Kelchtermans, H., de Groot, P. G., & de Laat, B. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.07.023 · Cited by 35
Metadata
- Authors
- Shi, T., Giannakopoulos, B., Yan, X., Yu, P., Berndt, M. C., Andrews, R. K., Rivera, J., Iverson, G. M., Cockerill, K. A., Linnik, M. D., & Krilis, S. A.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2006-07-25
- Volume
- 54
- Issue
- 8
- Pages
- 2558-2567
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1974727307
- Cited by
- 167
- References
- 1
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anti–β2‐glycoprotein I antibodies in complex with β2‐glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib‐IX‐V. https://app.cochat.ai/papers/10.1002/art.21968
- The paper
- Shi, T., Giannakopoulos, B., Yan, X., Yu, P., Berndt, M. C., Andrews, R. K., Rivera, J., Iverson, G. M., Cockerill, K. A., Linnik, M. D., & Krilis, S. A. (2006). Anti–β2‐glycoprotein I antibodies in complex with β2‐glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib‐IX‐V. Arthritis & Rheumatism. https://doi.org/10.1002/art.21968
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.